Accepted for/Published in: Online Journal of Public Health Informatics
Date Submitted: Oct 10, 2025
Date Accepted: May 12, 2026
A Social Media Listening Study of Tweets Surrounding Pharmaceutical Drug Brands with Top Direct-to-Consumer TV Advertising Budgets
ABSTRACT
Background:
Direct-to-consumer (DTC) pharmaceutical advertising allots billions annually in the U.S., yet social media discourse of it remains underexamined.
Objective:
To see what user-generated topics are discussed for the biggest budgeted DTC pharmaceutical drugs and what uses and gratifications and agenda-setting themes emerged.
Methods:
This social listening study employs Brandwatch to analyze Twitter conversations (August 2021—August 2023) surrounding top-budgeted DTC brands. A dataset of 44,700 mentions from 26,800 unique authors was analyzed for content, sentiment, and thematic relevance using uses gratifications and agenda-setting frameworks.
Results:
Four dominant themes emerged: (1) patient experiences/testimonials, (2) drug pricing/insurance concerns, (3) pharmaceutical news, and (4) advertising commentary. The content shows a range of potentially agenda-setting topics, including the pharmaceutical companies, their DTC drugs, patient experiences, costs, insurance, and advertising commentary. Twitter/X is serving as a forum for pharmaceutical companies, their constituents, and social media health influencers to discuss topics related to top-spending DTC drugs. The uses and gratifications we found included information, entertainment, economic benefits, and social benefits, information being the most prevalent.
Conclusions:
Our study is an important glimpse into what is being discussed on Twitter/X by, with, and about pharmaceutical drugs that spend billions on advertising each year (Fierce Pharma, 2022). Although more tweets were neutral than positive or negative, the overall sentiment of the top terms was negative. The predominance of negative sentiment in our findings suggests that many social media users express apprehensions or criticisms about these drugs, highlighting the need for improved communication, transparency, and engagement strategies. Further implications are also discussed surrounding public policy and industry practice. Suggested future research directions include NodeXL network analysis and qualitative inquiry into user motivations.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.